Steris Corp. acquired the remaining stake in VTS Medical Systems, Inc. from its joint venture partner for approximately $19 million.
January 08, 2013
Share
Steris Corp. (NYSE:STE) acquired the remaining stake in VTS Medical Systems, Inc. from its joint venture partner for approximately $19 million in cash on December 27, 2012. Under the terms of agreement, Steris paid $19 million and deferred cash payments to be paid over a ten year period. With the acquisition, VTS Medical Systems, Inc. became a wholly owned subsidiary of Steris Corp. and will be integrated into Steris Corp.'s healthcare segment within the surgical solutions business unit. Tony Kuhel of Thompson Hine LLP acted as legal advisor for Steris.
Steris Corp. (NYSE:STE) completed the acquisition of the remaining stake in VTS Medical Systems, Inc. from its joint venture partner on December 27, 2012.
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows:
- sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals);
- development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide;
- manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers.
Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%).
Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).